CAS RN: 2756334-24-2
2(1H)-Quinoxalinone, 7-bromo-8-fluoro-3,4-dihydro-3-methyl-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250925
100mg / 250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2756334-24-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
2756334-24-2 / 7-bromo-8-fluoro-3-methyl-3,4-dihydro-1H-quinoxalin-2-one
Standard CAS: 2756334-24-2
Multi CAS: No
Basic Information
copy
CAS
2756334-24-2 copy
Multi CAS
No copy
Molecular Formula
BC9H8N2ORf copy
Molecular Weight
259.070000 copy
Exact Mass
257.980400 copy
InChI
InChI=1S/C9H8BrFN2O/c1-4-9(14)13-8-6(12-4)3-2-5(10)7(8)11/h2-4,12H,1H3,(H,13,14) copy
InChIKey
AJCWZWOCIRHINF-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.22 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
55.81 copy
TPSA
41.13 copy
LogP / Solubility
WLOGP
2.34 copy
MLOGP
2.07 copy
XLogP3
2.1 copy
Consensus LogP
2.17 copy
Log S (ESOL)
-3.24 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.37 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.29 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.64 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy